Regulatory News
Tuesday, July 5, 2016
BRIEF-Sanofi Genzyme says Saskatchewan has added Lemtrada to province's MS drugs program
* Saskatchewan has added Lemtrada to province's MS drugs
program for eligible people living with relapsing-remitting
multiple sclerosis
Source text for Eikon:
Further company coverage:
)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment